Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1755 ARTÍCULOS , VIENDO DEL 376 AL 390

Rational drug design strategies for the development of promising multi-target directed indole hybrids as Anti-Alzheimer agents

George N, Jawaid Akhtar M, Al Balushi KA, Alam Khan S.

Bioorg Chem. 2022 Oct;127:105941. doi: 10.1016/j.bioorg.2022.105941. Epub 2022 Jun 10.

Microglia: Friend and foe in tauopathy

Odfalk KF, Bieniek KF, Hopp SC.

Prog Neurobiol. 2022 Sep;216:102306. doi: 10.1016/j.pneurobio.2022.102306. Epub 2022 Jun 14.

Autologous skin-derived neural precursor cell therapy reverses canine Alzheimer dementia-like syndrome in a proof of concept veterinary trial

Valenzuela M, Duncan T, Abey A, Johnson A, Boulamatsis C, Dalton MA, Jacobson E, Brunel L, Child G, Simpson D, Buckland M, Lowe A, Siette J, Westbrook F, McGreevy P.

Stem Cell Res Ther. 2022 Jun 17;13(1):261. doi: 10.1186/s13287-022-02933-w.

The Ketogenic Diet and Alzheimer's Disease

Hersant H, Grossberg G.

J Nutr Health Aging. 2022;26(6):606-614. doi: 10.1007/s12603-022-1807-7.

Adipose tissue-derived stem cells as a potential candidate in treatment of Alzheimer's disease: A systematic review on preclinical studies

Madani Neishaboori A, Eshraghi A, Tasouji Asl A, Shariatpanahi M, Yousefifard M, Gorji A.

Pharmacol Res Perspect. 2022 Aug;10(4):e00977. doi: 10.1002/prp2.977.

Gastrointestinal Changes and Alzheimer's Disease

Sohrabi M, Sahu B, Kaur H, Hasler WA, Prakash A, Combs CK.

Curr Alzheimer Res. 2022;19(5):335-350. doi: 10.2174/1567205019666220617121255.

Non-Coding RNAs as Novel Regulators of Neuroinflammation in Alzheimer's Disease

Liu Y, Cheng X, Li H, Hui S, Zhang Z, Xiao Y, Peng W.

Front Immunol. 2022 Jun 2;13:908076. doi: 10.3389/fimmu.2022.908076. eCollection 2022.

Do genetic factors contribute to sex-specific differences in resilience to amyloid pathology?

Groot C, Holstege H, Ossenkoppele R.

Brain. 2022 Jul 29;145(7):2239-2241. doi: 10.1093/brain/awac216.

Anti-amyloid agents for treating incipient Alzheimer's disease: a new hope?

Loureiro JC, Silva LFAL, Pais MV, Forlenza OV.

Braz J Psychiatry. 2022 Aug 20;44(4):368-369. doi: 10.47626/1516-4446-2022-2503.

The clinical and mechanistic roles of bile acids in depression, Alzheimer's disease, and stroke

Lirong W, Mingliang Z, Mengci L, Qihao G, Zhenxing R, Xiaojiao Z, Tianlu C.

Proteomics. 2022 Aug;22(15-16):e2100324. doi: 10.1002/pmic.202100324. Epub 2022 Jul 13.

Neuronal hyperexcitability in Alzheimer's disease: what are the drivers behind this aberrant phenotype?

Targa Dias Anastacio H, Matosin N, Ooi L.

Transl Psychiatry. 2022 Jun 22;12(1):257. doi: 10.1038/s41398-022-02024-7.

Therapeutic nanotechnologies for Alzheimer's disease: A critical analysis of recent trends and findings

Delbreil P, Rabanel JM, Banquy X, Brambilla D.

Adv Drug Deliv Rev. 2022 Aug;187:114397. doi: 10.1016/j.addr.2022.114397. Epub 2022 Jun 20.

Innate Immune Cell Death in Neuroinflammation and Alzheimer's Disease

Rajesh Y, Kanneganti TD.

Cells. 2022 Jun 10;11(12):1885. doi: 10.3390/cells11121885.

Dysregulated Ca(2+) Homeostasis as a Central Theme in Neurodegeneration: Lessons from Alzheimer's Disease and Wolfram Syndrome

Callens M, Loncke J, Bultynck G.

Cells. 2022 Jun 18;11(12):1963. doi: 10.3390/cells11121963.

Alzheimer's Disease Connected Genes in the Post-Ischemic Hippocampus and Temporal Cortex

Pluta R.

Genes (Basel). 2022 Jun 14;13(6):1059. doi: 10.3390/genes13061059.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias